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Abstract
Essentially all vitamins exist with multiple nutritionally active chemical species often called vitamers. Our
quantitative understanding of the bioactivity and bioavailability of the various members of each vitamin
family has increased markedly, but many issues remain to be resolved concerning the reporting and use of
analytical data. Modern methods of vitamin analysis rely heavily on chromatographic techniques that
generally allow the measurement of the individual chemical forms of vitamins. Typical applications of food
analysis include the evaluation of shelf life and storage stability, monitoring of nutrient retention during food
processing, developing food composition databases and data needed for food labeling, assessing dietary
adequacy and evaluating epidemiological relationships between diet and disease. Although the usage of
analytical data varies depending on the situation, important issues regarding how best to present and
interpret the data in light of the presence of multiple vitamers are common to all aspects of food analysis. In
this review, we will evaluate the existence of vitamers that exhibit differences in bioactivity or bioavailability,
consider when there is a need to address differences in bioactivity or bioavailability of vitamers, and then
consider alternative approaches and possible ways to improve the reporting of data. Major examples are
taken from literature and experience with vitamin B6 and folate.
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M
ost of the vitamins exist as groups of chemi-
cally related compounds having similar biolo-
gical activity capable of meeting a nutritional
requirement (frequently called ‘vitamers’). The usage of
the term vitamer dates back to the 1940s (e.g. 1).
Criticisms of this terminology have been raised since
the era of its inception (e.g. 2); however, this terminology
will be continued for this review in view of its widespread
usage and the lack of suitable alternatives.
The existence of multiple vitamers complicates many
aspects of the nutrient analysis in foods and diet samples.
For example, analytical method development must ac-
count for all nutritionally active forms of a vitamin.
Although this would seem to be an obvious requirement,
it often complicates the development, selection and
interpretation of methods for food analysis in situations
involving vitamers for which stability is poor or reliable
reference standards cannot be obtained commercially.
This is especially the case for vitamins in which sub-
stantial differences in bioactivity or bioavailability may
exist. This diversity of vitamer forms also complicates the
reporting and interpretation of analytical results and also
complicates the development of reliable analytical meth-
ods. When methods of analysis are chosen carefully and
validated properly, such procedures can provide highly
reliable information regarding the vitamer forms in
individual foods and diets. This ability to measure
individual vitamer forms in foods constitutes a major
attribute of chromatographic methods over traditional,
less-specific methods.
But in spite of this modern analytical power, the
following questions illustrate the complexity of this
area, including: (a) In which cases of food analysis is
there a need to consider differences in vitamer bioactivity
and/or bioavailability? (b) Does the analytical method
being used allow measurement of all biologically active
vitamers? (c) Is our understanding of the bioactivity and
bioavailability of particular vitamers sufficient to allow
reliable adjustments of food composition data to reflect
nutritional properties? (d) Can nutritional requirements
and food labeling be expressed in a way that incorporates
the differences in bioavailability or bioactivities among
vitamers?
Whereas the existence of differences in bioactivity/
bioavailability among vitamers is widely recognized,
situations differ regarding how to address this issue
when interpreting and reporting analytical data. Which
approach to use depends largely on the reason for the
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cation of the data. In this short discussion, we will
consider which of the vitamins exhibit substantial differ-
ences in bioavailability or bioactivity among vitamers,
issues in the selection and/or development of assay
methods, and approaches in the application of the data
to make nutritional inferences.
Vitamer forms, bioavailability, and bioactivity
Before discussing how to address issues of bioavailability
and bioactivity in the reporting of analytical data, a
summary of the vitamins for which multiple vitamers
exist is necessary as a starting point. Table 1 provides an
overview of the major forms of vitamins and brief
commentary regarding their dietary roles and issues
pertaining to bioavailability or bioactivity. Whereas a
comprehensive evaluation of this topic is beyond the
scope of the present review, we will consider general
approaches and identify major issues. We also will discuss
the feasibility of developing generalized approaches to
account for differences in bioavailability or bioactivity.
The first requirement in making such assessment is
defining terms and evaluating the situation with respect
to the various vitamins. The reader will note that, in
several cases, differentiating the terms bioavailability and
bioactivity is difficult due to the overlap of these concepts
and methods used for their experimental evaluation.
Bioactivity
Bioactivity refers to the biological activity (i.e. vitamin
activity) of a vitamer tested relative to the appropriate
reference form of that vitamin. Although this is
conceptually simple, the actual ranking in bioactivity
for vitamers often varies considerably in research studies
and reported in the scientific literature. Such variation
in apparent bioactivity of vitamers can be due to
differences in response of the experimental model used
(e.g. bacteria, rats, chicks, or humans), the experimental
design involving acute (bolus) or chronic administra-
tion, the dose employed, and the criterion of response
(e.g. animal growth or prevention of deficiency symp-
toms or use of a metabolic biomarker in animal or
human studies).
The best characterized examples of differences in
bioactivity among vitamers exist for the fat soluble
vitamins. This has long been recognized and the largely
discontinued system of international units was devised as
a means of addressing these differences. For example,
differences among the vitamin E vitamers have been
reported on the basis of bioassays largely reflecting
antioxidant activity (e.g. 3). Since bioactivity of vitamin
E vitamers varies, expressing analytical data as total
vitamin E yields an ambiguous result and presenting data
individually for each of the tocopherols is preferable.
More recent understanding of the specific biological role
of a-tocopherol has led to the development of Recom-
mended Dietary Allowances (RDA values) for vitamin E
solely on the basis of a-tocopherol (4). For this reason,
presenting data for a-tocopherol alone also is essential in
conveying vitamin E activity. The natural stereochemical
form of a-tocopherol is RRR-a-tocopherol, which ex-
hibits greatest vitamin E activity of the eight possible
diastereoisomeric forms (5). Such differences among
stereochemical forms must be recognizedwhen presenting
analytical data for supplements or fortified food in which
other less active a-tocopherol diastereoisomeric species
may be present. For example, the fully racemic form
(all-rac-a-tocopherol) exhibits only 50% activity of natu-
rally occurring RRR-a-tocopherol.
In the case of vitamin K, analytical data are most often
presented as phylloquinone, the primary form of vitamin
K in foods. However, for foods containing lipids prepared
from hydrogenated plant oils, a separate listing for
dihydrophylloquinone (6) would be preferable in view of
its lower vitamin K activity. Menaquinones constituting
the vitamin K2 group are products of bacterial synthesis
with variable isoprenoid chain length (7). The long chain
menaquinones found commonly in human tissues pre-
sumably are derived from intestinal bacterial synthesis as
well as from certain fermented foods. In contrast, the
presence of menaquinone-4 (i.e. having 4 isoprenoid
units) in tissues is a result of mammalian metabolic
conversion from phylloquinone. The relative qualitative
and quantitative activities of dietary forms of phylloqui-
none and menaquinone forms have not been fully
determined. Evidence from epidemiological (8) and
clinical studies (9) suggest that differences exist among
vitamin K species with respect to maintaining cardiovas-
cular and bone health. Thus, providing analytical data on
the individual forms of vitamin K in food analysis and
dietary studies is warranted.
Analytical data for vitamin D2 and D3 are generally
summed, for example in the USDA National Nutrient
Database for Standard Reference (10). Evidence of
greater activity of vitamin D3 than D2 (11), including
an activity ratio estimated to be 9.5:1(12), suggests that
individual listings for these vitamin D vitamers would
be preferable to facilitate nutritional interpretation
as needed. For vitamin A, similar vitamin activity is
generally observed among common dietary vitamers
retinol, retinaldehyde, and added retinyl esters; however,
the potential exists for the generation of corresponding
cis-isomers having lesser vitamin A activity as a result of
the thermal processing of foods. Although the activity of
cis-isomers has been determined (13), analytical data for
cis-isomers of vitamin A compounds are generally not
reported in food data base tabulations in view of
difficulties in their measurement and variability in their
extent of formation.
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Vitamin Chemical forms Comments
Vitamin A Retinol Approximately full bioavailability
Retinyl esters Full bioavailability of retinyl acetate and palmitate




Vitamin D D3, Cholecalciferol Evidence of greater activity of D3 than D2
D2, Ergocalciferol
25-Hydroxyvitamin D forms Lower content but higher bioavailability than parent (nonhydroxylated) vitamin
D compounds
Vitamin E a-Tocopherol a-Tocopherol exhibits primary in vivo activity. Greatest activity in natural RRR
stereochemical form
a-Tocopheryl acetate Acetate and other esters are fully available  common form used in fortification
b-tocopherol Primarily contributes antioxidant activity
d-tocopherol Primarily contributes antioxidant activity
g-tocopherol Primarily contributes antioxidant activity
Tocotrienols Primarily contributes antioxidant activity
Vitamin K Phylloquinone (K1) Synthesized in plants  primary dietary form
Menaquinone-n (K2, MK-n) Bacterial synthesis
MK-4 Synthetic; also produced in vivo from K2 sources
Dihydrophylloquinone Produced during hydrogenation of plant oils; reduced activity
Menadiones (K3) Synthetic; highly available
Thiamin Thiamin Vitamers have equivalent activity and bioavailability
Thiamin phosphates
Riboflavin Riboflavin Riboflavin, FAD and FMN have approximately equivalent activity and
bioavailability
Flavin mononucleotide (FMN)
Flavin adenine dinucleotide (FAD)
Minor forms Probably contribute to activity.
Niacin Nicotinic acid Full niacin activity
Nicotinamide Full niacin activity
NAD & NADP Highly available
NADH & NADPH Apparent gastric instability
Nicotinamide riboside Probably contributes to total niacin activity in milk
Bound forms of niacin Little availability unless released by alkaline treatment
Vitamin B6 Pyridoxine Full activity and bioavailability
Pyridoxal & pyridoxamine Approximately equivalent to pyridoxine; occasionally reported to have slightly
lower bioactivity
B6 5’-phosphate vitamers Similar to bioavailability to nonphosphorylated vitamers
Pyridoxine-5’-b-D-glucoside Approximately 50% (human) bioavailability
4-Pyridoxic acid Catabolic product inactive
o-Pyridoxyllysine A protein bound complex of vitamin B6 formed during food processing/storage.
Partial (50%) bioavailability; o-pyridoxyllysine is not detected in routine
methods of vitamin B6 analysis
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vitamers often exhibit only small differences in inherent
bioactivity, although variability in bioavailability may
occur. Approximately equivalent bioactivity appears to
be the case for the principal vitamers of thiamin, niacin,
riboflavin, pantothenic acid, folate, and vitamin B12. This
also is the case for vitamin B6, in spite of reports of
somewhat lower activity of pyridoxal and pyridoxamine
than pyridoxine in some experimental approaches
(e.g. 14). Such small differences appear to have little
nutritional importance. In contrast, niacin constitutes an
interesting case in which, in principle, all common dietary
forms (i.e. nicotinic acid, nicotinamide, NAD and
NADP) are expected to have similar nutritional activity
(15) but the reduced nucleotide forms NADH and
NADPH appear to exhibit lower bioactivity. The ob-
served lower bioactivity of NADH and NADPH pre-
sumably is attributable to gastric instability due to the
acid lability of these vitamers (16). Changes in the
proportions of niacin vitamers during corn maturation
are associated with altered nutritional properties for this
reason (17, 18). It should be noted that a form of niacin
identified in milk (nicotinamide riboside) appears to
contribute niacin activity but its quantitative importance
in milk (19) and potentially other foods remains unclear.
Although it is generally prudent to report individual
vitamers in food analysis, at present there is little reason
to consider adjusting results for the purpose of equating
the bioactivity of vitamers at this time.
Bioavailability
The term bioavailability in the nutritional context typi-
cally is defined more broadly than in the pharmacological
context. A common definition is the ‘fraction of an
ingested nutrient that is available for utilization in normal
physiologic functions and for storage’ (20). Whereas this
is not universally applicable (for example, water-soluble
vitamins generally do not undergo storage), the concept
provides a workable framework in terms of the relative
absorption and utilization of dietary vitamins. It should
be recognized, however, that bioavailability is a complex
and variable concept (21) that often cannot be reliably
employed in databases, labeling and many forms of
dietary assessment. Moreover, nutrient bioavailability in
Table 1 (Continued)
Vitamin Chemical forms Comments
Pantothenic acid Pantothenic acid Full activity and bioavailability
Coenzyme A Approximately full bioavailability
Pantothenol Approximately full activity and bioavailability
4’-Phosphopantetheine Approximately full activity and bioavailability
Biotin Biotin Common natural form: highly available
Biocytin (o-biotinyl lysine) Protein form, also derived from turnover of biotin enzymes; slower absorption
than free biotin
Catabolic products inactive
Folate Folic acid Highly available in foods and supplements. High doses may exceed metabolic
capacity.
Naturally occurring folates: Often incomplete bioavailability probably due to food matrix and entrapment
Dihydrofolate Unstable  minor food folate
Tetrahydrofolate (THF) Common natural folate: unstable; may undergo degradation if GI tract
5-Methyltetrahydrofolate Major naturally occurring folate vitamer
5-Formyltetrahydrofolate Common natural folate
10-Formyltetrahydrofolate Common natural folate
5,10-Methenyltetrahydrofolate Common natural folate; also formed in acidic equilibrium with 10-formylTHF
5,10-Methylenetetrahydrofolate Readily dissociates when heated to yield THF
10-Formyldihydrofolate Oxidation product of 10-formylTHF
10-Formyl-folic acid Oxidation product of 10-formyldihydrofolate
Vitamin B12 Cyanocobalamin Predominant synthetic B12 vitamer
Methylcobalamin Common vitamin B12 coenzyme form
Adenosylcobalamin Common vitamin B12 coenzyme form
Aquacobalamin Common in vivo form
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individual foods, probably is a more important consid-
eration with respect to predicting health outcomes (22).
Mechanisms responsible for differences in bioavailabil-
ity of various types of vitamins or among vitamers often
can be explained on the basis of differences in intestinal
absorption (including variation in stability in the GI tract
as described above) and/or differences in the rate or extent
of release of the active vitamer moiety from a conjugated
form (e.g. pyridoxine-b-D-glucoside and various folates;
see below). The vitamin A-active carotenoids exhibit
variability in Retinol Activity Equivalents (RAE) and,
thus, the ratios used for the calculation of RAE. These
differences among carotenoids apparently can be attrib-
uted to incomplete cleavage during digestion to release
retinaldehyde and also variation whether one or two
componentsof thecarotenoid molecule canyield anactive
form of vitamin A following carotenoid cleavage. With
respect to the carotenoid example, the US Institute of
Medicine has established the following conversion factors
(4). The IOM (4) defined the following values in which
1 mg retinol is assumed to be derived from: 2 mg of
supplemental b-carotene, 12 mg dietary b-carotene,
24 mg a-carotene, and 24 mg a-cryptoxanthin. In spite
of some disagreement regarding the merits of the IOM
recommendations by certain investigators in this field (e.g.
23), this approach provides a reasonable framework for
estimating the contributions of carotenoids to dietary
vitaminAactivity.AsisthecasewithpreformedvitaminA
species, conversion of carotenoids to cis-isomers leads to
reduced activity as vitamin A (24). These differences
presumablyareattributabletothelesservitaminAactivity
of cis-forms of retinaldehyde released from the cis-
carotenoid isomers.
Other examples of incomplete bioavailability and
variation among vitamers exist for the B vitamins. In
the case of ‘bound’ forms of niacin in grains, which are
linked either to carbohydrate or as peptidyl forms (25, 26),
very low bioavailability is observed unless the grains are
subjected to alkaline treatment (e.g. as in tortilla produc-
tion). With respect to vitamin B6, pyridoxine-b-D-gluco-
side exists commonly throughout the plant kingdom (26,
27), constitutes animportant factor that affects theoverall
bioavailability of this vitamin in a wide range of plant-
derived foods. In spite of initial research showing approxi-
mately 25% bioavailability of PN-glucoside as a source of
vitamin B6 in rats (28), later work showed conclusively
that humans exhibited approximately 50% bioavailability
for PN-glucoside (2931). Free pyridoxine HCl added in
food fortification undergoes nearly complete absorption.
In the case of vitamin B12, absorption depends on
proper functioning of integrated steps in digestion includ-
ingtherelease ofvitaminB12from dietaryprotein, specific
binding in the stomach to haptocorrin, transfer in the
small intestine to the stomach-derived B12 binding protein
called intrinsic factor, and then carrier mediated absorp-
tion in the ileum. Any digestive disorder that interferes
with this process, including physiological or pharmacolo-
gical interference with gastric secretions, can directly
interfere with vitamin B12 absorption (32). In addition,
impaired gastric secretion often is associated with malab-
sorption of naturally occurring vitamin B12 in food even
though the absorption of synthetic vitamin B12 might be
unimpaired (33). Classic research by Dolscherholmen and
associates (3436) involving intrinsic enrichment of fish,
eggs and chicken meat showed markedly depressed
absorption of the radiolabeled vitamin B12 in patients
with pernicious anemia due to impaired production of
intrinsicfactor(35).Suchstudieshavebeenextendedusing
accelerator mass spectrometry techniques (37).
The bioavailability of folate is a complex topic with
variability reported for the bioavailability of naturally
occurring folate that may be due to entrapment in the
food matrix, complicated by the existence of a variety of
natural tetrahydrofolates (THF) varying in polyglutamyl
chain length and folic acid that may be added in food
fortification. The dietary and physiological factors affect-
ing folate bioavailability have been discussed previously
(22, 38). Most evidence suggests that the bioavailability of
naturally occurring food folates is less than that of added
folic acid (22, 38), although caution should be exercised
in interpreting literature based on animal bioassays of
folate bioavailability. Whereas bioassays using rodents are
useful in some applications, they may have little value in
predicting the bioavailability of dietary polyglutamyl
folates in human diets in view of the differences in
intestinal deglutamylation mechanism and enzymes
involved. Assumed incomplete deconjugation of polyglu-
tamyl folates has led to the assumption that polygluta-
mylation of natural folates constitutes a mechanism
responsible for incomplete bioavailability of dietary
folates; however, it must be recognized that this assump-
tion is not fully supported by the literature (22, 38).
Indeed, reports of relationships between folylpolyglu-
tamate chain length and their in vivo bioavailability range
from 50% to 100%. These inconsistent experimental
findings likely can be attributed to variation in the
protocols used, dosages employed and, potentially, analy-
tical inaccuracies. Entrapment in the food matrix (i.e.
cellular structure, etc.) presumably contributes to incom-
plete bioavailability of food folates. Small doses of folic
acid and reduced folates exhibit effective and equivalent
absorption (39), whereas larger doses (several hundred
mg) show differences in post-absorptive distribution and
retention in vivo (40, 41). For this reason, one group of
investigators has criticized the use of folic acid
as a reference material in earlier folate bioavailability
protocols (e.g. 42).
However, this reviewer considers such arguments
to have little practical relevance because the primary
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rather than absolute bioavailability, and using the form of
this vitamin (i.e. folic acid) that is the common supple-
mental form and food fortificant as a reference makes
conceptual sense as well. Studies of the bioavailability of
folic acid from fortified cereal grain food products
showed effective absorption (43, 44). As will be discussed
further, the development of the term Dietary Folate
Equivalents (DFE) constitutes an approach to account
for the generally greater absorption of added folic acid
than naturally occurring food folate (45).
Evaluation, selection, and development of analytical
methods
Principles of vitamin assay in food analysis to allow
inferences
Several principles can be stated regarding for the devel-
opment or selection of methods to be used for the
determination of vitamins in foods. These include: (a)
ability to distinguish and individually quantify all nu-
tritionally active vitamers; (b) ability to distinguish and
individually quantify all significant precursors or pro-
vitamin forms that contribute to overall vitamin activity;
(c) existence and accessibility of appropriate standards
for all vitamer forms; and (d) existence of appropriate
validation and quality control protocols. Unlike tradi-
tional methods in which the entire assay depends on the
preparation of a single accurate working standard,
measurement of individual vitamer forms requires the
preparation of a standard for each compound measured.
This complicates the analysis and puts greater emphasis
on the proper routine standardization of the method than
would be required for more traditional methods.
Methods to determine total vitamin content
Early approaches to the determination of vitamins largely
relied on procedures using either microbial or chemical
methods that one hoped provided a measurement of the
total (i.e. aggregate) of the nutritionally active vitamer
forms. More thorough examination of the response of
such methods occasionally provided evidence of non-
uniform response among prominent vitamer forms and,
thus, a large potential for inaccuracy when measuring
total vitamin content. Such issues have been reported for
typical microbiological assays for vitamin B6 (e.g. 46) and
folate (e.g. 47). Analytical bias also could arise in both
microbiological and chemical assays for total content of
vitamins if differences existed among vitamers with
respect to their efficiency of extraction and/or stability
during such preparative phases of assays. For reasons
such as these and in view of the potential for varying
bioactivity and bioavailability of vitamers, the need for
improved methods of vitamin analysis is clear. Further-
more, such discussions point clearly to the importance of
developing and using methods that allow accurate
quantification of individual vitamers wherever possible.
A need also frequently exists to differentiate between
added and naturally occurring vitamers.
The advent of high performance liquid chromatogra-
phy (HPLC) transformed almost all areas of vitamin
analysis and greatly facilitated the measurement of
individual vitamers. In spite of the power of HPLC and
its widespread application, surprising practical and con-
ceptual limitations remain in some of the methods
appearing even recently in peer-reviewed literature. An
old and frequently told story of analytical chemistry
lectures about an inebriated fellow looking for his lost
wallet illustrates one major point very well. When asked
why he was looking for it under the lamp post, he
responded ‘because that is where the light is.’ The key
point in our context is that the analyst should make every
effort to employ methods that can detect and quantify all
relevant forms of target vitamin, not just those that are
easily detected or for which standards can be readily
obtained. In the area of vitamin analysis, some of the
potentially excellent published methods should be viewed
as inadequate because either the method used did not
provide for detection of all nutritionally active vitamers
or else the investigators apparently did not recognize the
need for quantifying certain vitamers. The measurement
of folate and vitamin B6 vitamers in foods constitute
good examples of these issues, as discussed below.
Naturally occurring folate exists as an array of
THF species including THF, 5-methyl-THF, 5-formyl-
THF, 10-formyl-THF, 5,10-methylene-THF, and 5,10-
methenyl-THF, with very small amounts of 7,8-dihydro-
folate (DHF) also present. In natural products including
plant and animal tissues and cereal grains, 10-formyl-
THF and 5,10-methenyl-THF together can constitute up
to 1535% of the total folate pool in certain materials
(e.g. 48, 49). Although several approaches have allowed
successful measurement of folate vitamers directly as
their various polyglutamyl forms (e.g. 5052), difficulty in
standardizing such methods makes their routine use in
food analysis difficult. The challenge of measuring all
polyglutamyl forms of each vitamer species routinely is
bypassed by enzymatic hydrolysis so that each vitamer
species is measured as the monoglutamyl form, but
verification of full hydrolysis should be performed for
each type of sample analyzed (e.g. 53).
Accounting for all types of the formyl folates constitu-
tes another problem that has not been fully addressed in
some published methods. 5-formyl-THF, 10-formyl-THF
and 5,10-methenyl-THF are inter-convertible depending
on pH and temperature used in extraction, preliminary
treatment, and HPLC separation (see 52). Although the
5-formyl-THF pool exhibits quite good stability; the
measurement of 10-formyl-THF is more problematic
due to these interconversions and susceptibility to
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5,10-methenyl-THF in acidic conditions (54) such as
those used in affinity chromatographic purification and
reverse phase HPLC with an acidic mobile phase allows
convenient measurement ofthis vitamer as 5,10-methenyl-
THF (e.g. 49, 55). Differentiation between 10-formyl-
THF and 5,10-methenyl-THF present in a food sample is
difficult for this reason, but reporting their sum would
pose no problem in nutritional interpretation of the data
since these vitamers would exhibit comparable bioactivity
and bioavailability as folate sources. Two oxidation
products of 10-formyl-THF also must be considered:
10-formyl-DHF and 10-formyl-folic acid.
A number of analytical methods for measurement of
food folate published over the past few years have
provided for the measurement of 10-formyl-folic acid,
presumably because of the stability and ease of handling
of this compound as well its ease of preparation and
commercial availability for use as a standard. However,
the nutritionally active intermediate in the oxidation of
10-formyl-THF to 10-formyl-folic acid is 10-formyl-
DHF, and very few published methods include provision
for its measurement. Our analyses of natural (i.e. not
added) folates in cereal grain foods (47), and plant tissues
(55, 56) have shown variable but measureable amounts of
10-formyl-DHF. It is unlikely that any significant amount
of 10-formyl-DHF exists naturally in living plant and
animal tissue, so the detection of 10-formyl-DHF and
10-formyl-folic acid in freshly obtained samples repre-
sents small and largely unavoidable oxidation of
10-formyl-THF during the preparative and analytical
procedures. Since postharvest handling, processing and
distribution of foods provide ample opportunity for the
formation of these nutritionally active oxidation
products, HPLC methods of folate analysis should allow
for their measurement in addition to the major natural
and added folates. The advent of labeling and databases
expressing Dietary Folate Equivalents (as discussed
later), puts an added requirement on method selection
since the procedure must differentiate between natural
folates and added folic acid. Although several
well-validated procedures exist for this application
(e.g. 48, 57, 58), none of these has the Association of
Official Analytical Chemists International (AOAC)
‘Official Method’ designation.
Vitamin B6 represents another example of a challen-
ging aspect of food analysis because of its multiple
vitamer forms including pyridoxine (PN)-glucoside in
plants. Various validated methods exist for the measure-
ment of B6 vitamers individually, including PN-glucoside
(e.g. 27, 28, 59). This approach is needed to allow
the user to make nutritional inferences by accounting
for the reduced bioavailability of PN-glucoside. It is
disconcerting that a number of published procedures
for the measurement of vitamin B6 either neglect the
glycosylated form entirely or else hydrolyze it to pyridox-
ine and measure total pyridoxine. The latter approach
would be sufficient for animal-derived foods, but for
plant foods that contain a substantial fraction of vitamin
B6 as PN-glucoside, such methods would lead to over-
estimation of overall nutritional content since the result-
ing data would not reflect the content and partial
bioavailability of PN-glucoside. Whereas the absence of
a commercial PN-glucoside standard complicates both
the development of new methods and the calibration of
existing procedures, simple and reliable methods do exist
for its biosynthesis and purification (60).
Considering the analytical context
As mentioned earlier, the measurement of vitamins is
conducted for many reasons and in many situations.
Whether there is a need to make nutritional inferences
adjusting for differences in bioactivity and/or bioavail-
ability depends on the particular situation. The following
illustrates variation in context and usage of data.
(1) Analysis for process monitoring and process control:
When analyses are conducted in a food manufactur-
ing setting to monitor nutrient stability for proces-
sing control, accuracy of vitamin addition during
fortification, or to evaluate shelf life, the resulting
data are largely for internal use. Thus, there is little
need for the reporting of data to incorporate
adjustment for the variations in bioactivity or
bioavailability among vitamers.
(2) Nutritional labeling: Nutrition information panels
in such labeling generally are derived from databases
generated by the manufacturer from direct analysis
of finished food products with representative
sampling, appropriate analysis and statistical eva-
luation. Sound analytical data are required in
developing such databases to support the content
claims made on the label, although the specifics of
nutritional labeling policy, including analytical re-
quirements, vary from country to country (e.g. 61,
62). The purpose of nutritional labeling is to convey
to the consumer actual nutritional content, on a per
serving basis, to facilitate food selection and dietary
formulations by interested consumers, rather than
being a detailed data sheet or certificate of analysis
for the contents of each package. As practiced in the
United States, the Food and Drug Administration
(FDA) policy requires the content of naturally
occurring vitamins in the package to be present at
no less than 80% of the amount shown on the
nutrition label (62). In contrast, the content of
added vitamins must be no less than 100% of the
label value (62). Because this requirement applies
throughout the shelf life of the product during which
losses of vitamin content can occur, appropriate
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Both analytical and compositional variability must
be taken into account. For the purpose of nutri-
tional labeling, regulatory agencies generally expect
the use of validated methods with some form of
official designation such as the ‘Official Methods’ of
the AOAC. Indeed, the FDA (62) has stated: ‘FDA’s
continuing policy since the 1970s assigns the man-
ufacturer the responsibility for assuring the validity
of a product label’s stated nutrient values.
Accordingly, the source of the data used to calculate
nutrition label values is the prerogative of the
manufacturer, but FDA’s policy recommends that
the nutrient values for labeling be based on product
composition, as determined by laboratory analysis
of each nutrient. FDA continues to recommend the
use of the Official Methods of the AOAC, with
non-AOAC Official Methods used only in the
absence of appropriate AOAC validated methods.
For each product that is included in a nutrition
labeling data base submitted to FDA, the agency
requests that the developer include a table identify-
ing proposed analytical methods that were used in
the analysis of each nutrient, with accompanying
information containing validation of the method
used by the onsite or commercial laboratory for the
matrix of interest.’ Unfortunately, information
regarding the actual methods used and the
validation protocols employed to generate these
databases are not easily determined by users. One
should recognize that many modern analytical
methods and approaches exist that meet current
needs in vitamin analysis, particularly with respect
to proper measurement of individual vitamers.
Unfortunately, most of these have not been
evaluated for ‘Official Method’ status or otherwise
designated as validated methods even though scien-
tific validation has been performed. A distinct need
exists for support of methods development but a
great need also exists for validation of more modern
methods to achieve official methods status and
regulatory approval.
(3) Food Composition Databases. The expansion of
food composition data bases such as the USDA
National Nutrient Database for Standard Reference
(10) constitutes a major service that makes food
composition data readily accessible to the scientific
community and the public. These facilitate evalua-
tion of dietary adequacy in many facets of human
nutrition, including clinical nutrition. The food
composition databases also serve as powerful tools
in evaluating diet-disease relationships in clinical
and epidemiological studies. Unlike databases used
for nutritional labeling of foods, the listings in the
USDA National Nutrient Database for Standard
Reference (10) provide much more complete array of
data for total nutrient content and a much more
comprehensive listing of major vitamer forms that
allow listings and inferences regarding the primary
natural and added forms of vitamins, as illustrated
in Table 2. The USDA database and its online
format illustrate many very positive attributes and
serve as a very good example for making food
composition data available to a wide range of users.
In spite of the breadth and depth of coverage,
several aspects could be improved greatly to facil-
itate interpretation by interested users. First, there
should be a mechanism by which the user could
determine the analytical method employed. For
example, being able to determine whether a niacin
assay involved acid or alkaline extraction would help
a knowledgeable user to determine whether the
result listed reflected total (alkaline extraction/
hydrolysis) or biologically available (acid extrac-
tion/hydrolysis). This and many similar questions
could be easily resolved if reference citations or links
to methodologies were provided. Second, there is
currently no way to ascertain the quality of the data.
Providing some type of linkage to the sampling and
quality control procedures used also would aid
interested users in assessing data listings. Finally,
users would benefit if the procedures for adjusting
for differences in bioactivity and/or bioavailability
were clearly defined. For example, links to a
summary with definitions of terms such as Retinol
Activity Equivalents and Dietary Folate Equiva-
lents. As currently presented, the user cannot readily
interpret the meaning or intent of such terms used
throughout the database.
Suggestions for improving the reporting of data
The recommendations above would benefit the USDA
National Nutrient Database for Standard Reference (10)
but also would be applicable to and would benefit all
other food composition databases.
With respect to the vitamins used as primary examples
in this review, vitamin B6 and folate, this author proposes
several additional recommendations. For vitamin B6 in
fruits and vegetables (which account for approximately
half of dietary vitamin B6 intake), a system for expressing
total available vitamin B6 adjusting for the incomplete
bioavailability of PN-glucoside should be implemented.
PN-glucoside exhibits approximately 50% bioavailability
in humans (2931). For this purpose, a term such as
‘Bioavailable Vitamin B6 Equivalents’ would be defined
as: [total vitamin B6]  (0.5 * [PN-glucoside]). This is an
oversimplification since it adjusts only for the
well-characterized incomplete bioavailability of PN-
glucoside and ignores other factors affecting vitamin B6
bioavailability; however, this would serve as a useful
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Folate Equivalent’ concept have been discussed pre-
viously. ‘Dietary Folate Equivalents’ are defined as mg
food folate(1.7 x mg synthetic folic acid), with the 1.7
multiplier based on the ratio of assumed bioavailability of
folic acid added to food (assumed 85%) divided by the
assumed bioavailability of natural dietary folate (assumed
50%) (45). Whereas the merits of the assumptions of
absolute and relative bioavailabilities on which the multi-
plier is based can be argued, the concept and approach
are useful in illustrating the greater bioavailability of the
added folic acid (22). Since the Dietary Folate Equiva-
lents are firmly entrenched in widespread usage and even
serve as a basis for the folate RDA, making changes in
this approach is not recommended. However, users
should recognize that uncertainty does exist in the
quantitative concept of Dietary Folate Equivalents.
Summary, conclusions, and future directions
In summary, this review has illustrated many applications
of the measurement of vitamins and has presented many
examples illustrating the need for the measurement of
individual vitamers wherever possible. Since major objec-
tives of nutritional labeling and food composition
databases are to allow the user to make inferences
pertaining to food selection and diet composition, the
presentation of analytical data that reflects nutritional
properties to the greatest extent possible should remain
Table 2. Vitamins listed in the USDA National Nutrient Database for Standard Reference (Adapted from (7)). The various listing for the




Vitamin A, RAE mg, RAE Vitamin A activity adjusted for differences in bioavailability/bioactivity between
preformed vitamin A and vitamin A-active carotenoids
Retinol mg Individual values allow calculation of RAE
Carotene, beta mg Individual values allow calculation of RAE
Carotene, alpha mg Individual values allow calculation of RAE
Cryptoxanthin, beta mg Individual values allow calculation of RAE
Vitamin A, IU IU Vitamin A activity expressed in the IU system
Lycopene mg A carotenoid of interest regarding diet and health
LuteinZeaxanthin mg A carotenoid of interest regarding diet and health
Vitamin E (alpha-tocopherol) mg Considered the major vitamin E-active tocopherol
Vitamin E, added mg Added vitamin E expressed as alpha-tocopherol
Tocopherol, beta mg A tocopherol contributing antioxidant activity
Tocopherol, gamma mg A tocopherol contributing antioxidant activity
Tocopherol, delta mg A tocopherol contributing antioxidant activity
Vitamin D (D2D3) mg Total vitamin D (assumesactivity of D2 &D 3)
Vitamin D IU Vitamin D activity expressed in the IU system
Vitamin K (phylloquinone) mg Primary natural vitamin K vitamer
Vitamin C (total ascorbic acid) mg Ascorbic acid plus dehydroascorbic acid
Thiamin mg Total of thiamin and thiamin phosphates
Riboflavin mg Total of free riboflavin, FAD and FMN
Niacin mg Total niacin, sum of nicotinamide, nicotinic acid, NAD and NADP
Pantothenic acid mg Total pantothenic acid in microbial assay
Vitamin B6 mg Total of all vitamers (PN-glucoside included in pyridoxine total)
Folate, total mg Total folate, largely microbial assay
Folic acid mg Added folic acid, assumed to have 1.7 times greater bioavailability than natural
dietary folate
Folate, food mg Total naturally occurring folate
Folate, DFE mg DFE Total folate expressed as dietary folate equivalents giving greater weight to folic acid
assuming its greater bioavailability
Choline, total mg Sum of free choline, phosphorylcholine and phosphatidylcholine
Betaine mg A choline catabolite of interest as an alternative methyl donor
Vitamin B12 mg Total vitamin B12
Vitamin B12, added mg Added cyanocobalamin, assumed to have greater bioavailability (basis of RDA)
Accounting for differences in the bioactivity and bioavailability of vitamers
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(page number not for citation purpose)an objective. All databases that incorporate terms reflect-
ing aggregate bioactivity of vitamer forms should clearly
make the definitions clearly accessible to the users.
Furthermore, making information available about the
analytical methods and quality control protocols used
would greatly facilitate the interpretation of data by
scientific users. Finally, despite major advances in the
analytical chemistry of vitamin analysis, many needs
exist. In particular, new methods should allow the
measurement of individual vitamers and should avoid
approaches in which groups of vitamers are converted to
single analyte forms. Support from users and agencies
maintaining databases also is needed for the validation
and certification of new analytical methods to augment
and/or replace outdated ‘official methods.’
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